These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35016823)

  • 1. Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis.
    Shimizu K; Hirata H; Kabata D; Tokuhira N; Koide M; Ueda A; Tachino J; Shintani A; Uchiyama A; Fujino Y; Ogura H
    J Infect Chemother; 2022 Apr; 28(4):548-553. PubMed ID: 35016823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Ventilator-free days" composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis.
    Mady AF; Abdulrahman B; Mumtaz SA; Al-Odat MA; Kuhail A; Altoraifi R; Alshae R; Alharthy AM; Aletreby WT
    Heart Lung; 2022; 56():118-124. PubMed ID: 35839546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of Ivermectin in COVID-19 patients: A prospective study at a safety-net hospital.
    Ozer M; Goksu SY; Conception R; Ulker E; Balderas RM; Mahdi M; Manning Z; To K; Effendi M; Anandakrishnan R; Whitman M; Gugnani M
    J Med Virol; 2022 Apr; 94(4):1473-1480. PubMed ID: 34811753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
    Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
    JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Hosseini FS; Malektojari A; Ghazizadeh S; Hassaniazad M; Davoodian P; Dadvand H; Nikpoor AR; Nikoofal-Sahlabadi S; Kahoori S; Sepandi M; Hassanipour S; Fathalipour M
    Trials; 2021 Jan; 22(1):4. PubMed ID: 33397429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ventilator-free days with respiratory physiotherapy in critically ill patients with Coronavirus Disease 2019 (COVID-19) during the first pandemic wave. A propensity score-weighted analysis.
    Privitera E; Gambazza S; Rossi V; Santambrogio M; Binda F; Tarello D; Caiffa S; Turrin V; Casagrande C; Battaglini D; Panigada M; Fumagalli R; Pelosi P; Grasselli G
    Front Med (Lausanne); 2022; 9():994900. PubMed ID: 36172535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes Associated With Methylprednisolone in Mechanically Ventilated Patients With COVID-19.
    Nelson BC; Laracy J; Shoucri S; Dietz D; Zucker J; Patel N; Sobieszczyk ME; Kubin CJ; Gomez-Simmonds A
    Clin Infect Dis; 2021 May; 72(9):e367-e372. PubMed ID: 32772069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.
    Li Bassi G; Gibbons K; Suen JY; Dalton HJ; White N; Corley A; Shrapnel S; Hinton S; Forsyth S; Laffey JG; Fan E; Fanning JP; Panigada M; Bartlett R; Brodie D; Burrell A; Chiumello D; Elhazmi A; Esperatti M; Grasselli G; Hodgson C; Ichiba S; Luna C; Marwali E; Merson L; Murthy S; Nichol A; Ogino M; Pelosi P; Torres A; Ng PY; Fraser JF;
    Crit Care; 2022 May; 26(1):141. PubMed ID: 35581612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.
    Papamanoli A; Yoo J; Grewal P; Predun W; Hotelling J; Jacob R; Mojahedi A; Skopicki HA; Mansour M; Marcos LA; Kalogeropoulos AP
    Eur J Clin Invest; 2021 Feb; 51(2):e13458. PubMed ID: 33219551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
    Muller M; Lefebvre F; Harlay ML; Glady L; Becker G; Muller C; Aberkane O; Tawk M; Julians M; Romoli A; Hecketsweiler S; Schneider F; Pottecher J; Chamaraux-Tran TN
    Trials; 2021 Feb; 22(1):131. PubMed ID: 33573681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.
    Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY
    BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.
    Rajter JC; Sherman MS; Fatteh N; Vogel F; Sacks J; Rajter JJ
    Chest; 2021 Jan; 159(1):85-92. PubMed ID: 33065103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of prophylactic synbiotics with reduction in diarrhea and pneumonia in mechanically ventilated critically ill patients: A propensity score analysis.
    Shimizu K; Ogura H; Kabata D; Shintani A; Tasaki O; Ojima M; Ikeda M; Shimazu T
    J Infect Chemother; 2018 Oct; 24(10):795-801. PubMed ID: 30037757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.